Activating Transcription Factor 6 (ATF6) (N-Term) Peptide
Aperçu rapide pour Activating Transcription Factor 6 (ATF6) (N-Term) Peptide (ABIN8093910)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- ATF6 Peptide - N-terminal region
-
Séquence
- GLFHRLDEDW DSALFAELGY FTDTDELQLE AANETYENNF DNLDFDLDLM
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti- ATF6 Antibody (ARP97423_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ATF6 (Activating Transcription Factor 6 (ATF6))
-
Sujet
-
Background Information: This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis.
Alternative Symbols: ACHM7, ATF6A
-
Poids moléculaire
- 75 kDa
-
ID gène
- 22926
-
NCBI Accession
- NP_031374
-
UniProt
- P18850
Antigène
-